Concepedia

Christophe Martignier

CM

4

Publications

764

Citations

4

H-Index

2018

Active since

Affiliations

University of Lausanne(Current)

University of California, Los Angeles

University of Virginia Health System

University of Washington

The Netherlands Cancer Institute

Christophe Martignier is an author at University of Lausanne specializing in medicine, immunology, and tumor immunology.

ORCID

Top concepts

Publications per year

2018–2020

4

Publications

4

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Catherine S. Grasso, Jennifer Tsoi, Mykola Onyshchenko et al. · Cancer Cell · 2020 · 361 citations · Full text

, , +7

T cell–induced CSF1 promotes melanoma resistance to PD1 blockade

Natalie J. Neubert, Martina Schmittnaegel, Natacha Bordry et al. · Science Translational Medicine · 2018 · 292 citations · Full text

LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-cultures

Nicolas Gestermann, Damien Saugy, Christophe Martignier et al. · OncoImmunology · 2020 · 60 citations · Full text

, , +18

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Catherine S. Grasso, Jennifer Tsoi, Mykola Onyshchenko et al. · Cancer Cell · 2020 · 51 citations · Full text

, , +7

Rows per page

1–4 of 4